Portfolio News

November 10, 2020
Exclusive: Decheng's Inside View of Merck's $2.75 Billion Acquisition of VelosBio

November 5, 2020
Merck to buy VelosBio for $2.75 billion to bolster oncology pipeline

October 13, 2020
Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million Molecular, Point-of-Care COVID-19 Tests

October 12, 2020
Exclusive: How Sequencing Firm ReadCoor Came to be Acquired by 10x Genomics

October 9, 2020
Everest Medicines Raises $423 million in Hong Kong IPO

October 7, 2020
Mammoth Biosciences Founder, Professor Jennifer Doudna, Wins 2020 Nobel Prize in Chemistry

October 5, 2020
10x Genomics to Acquire ReadCoor for $350M

September 23, 2020
Exclusive: The Story Behind How Cirina, a $12 Million Hong Kong Diagnostics Startup, Became Part of Illumina

September 21, 2020
Illumina to Acquire GRAIL for $8 billion to Launch New Era of Cancer Detection

August 6, 2020
Checkmate Pharma Raises $75 Million IPO

July 28, 2020
Sema4 Closes $121 Million Series C

July 8, 2020
VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology

June 25, 2020
Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies

June 18, 2020
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101

June 12, 2020
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

June 10, 2020
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

June 10, 2020
Checkmate Pharmaceuticals Secures $85 Million in Series C Financing

June 4, 2020
Everest Medicines Completes US$310 Million Series C Financing

May 27, 2020
Gilead Sciences Signs $2 Billion Partnership with Arcus Biosciences

May 21, 2020
Mindstrong Announces $100M Funding Round to Scale its Virtual Mental Healthcare & Digital Symptom Measurement Offering

May 20, 2020
Mammoth Biosciences partners with GSK to develop handheld CRISPR-based COVID-19 test

May 11, 2020
Hummingbird Bioscience closes US$25M investment with Series B extension

May 6, 2020
GRAIL Announces $390 Million Series D Financing

January 30, 2020
Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products For Therapeutics and Diagnostics

January 10, 2020
ReadCoor, Inc. Announces $27 Million Series B Financing for Commercial Launch of 3D RNA, DNA, and Protein Spatial Sequencing Platform

January 9, 2020
Omniome Closes $60 Million Series C Financing to Advance Novel Genomic Sequencing Platform

December 17, 2019
KeChow Completes $45 Million Round for Novel Cancer Drug Development

December 12, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants

December 5, 2019
Hummingbird Bioscience Raises US$19 Million in Series B Financing

November 4, 2019
SinoMed, a Medical Device Company, Stages $50 Million IPO on the Shanghai STAR Exchange

October 25, 2019
BeyondSpring Announces Pricing of Ordinary Shares

August 29, 2019
Sema4 Lands New Investors, Continues to Expand

August 12, 2019
Atricure Offers $300M for SentreHeart

July 17, 2019
BeyondSpring Announces Pricing of Public Offering Ordinary Shares

June 26, 2019
Adaptive Biotechnologies Announces Pricing of Initial Public Offering

June 5, 2019
EpimAb Biotherapeutics Raises $74 million in Series B Financing

May 30, 2019
Adaptive Biotechnologies files for $230M IPO, banking on big Microsoft and Genentech deals

May 17, 2019
Hangzhou's AnHeart Completes $14.6 Million A Funding

February 14, 2019
Bioheng Closes $15 Million Funding for CAR-T Products

January 16, 2019
Alpine Immune Sciences Announces $25 Million Private Placement

January 3, 2019
Mindstrong Health Expands Series B Financing with $31M Investment

December 12, 2018
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing

October 30, 2018
Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

October 1, 2018
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic

August 8, 2018
Apexigen Raises $73 Million In Series B And Series C Financings

August 3, 2018
IMPACT Therapeutics Raises $30 Million In Series C Financing

July 30, 2018
Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology

July 17, 2018
Polares Raises $25M to Bring its 'Hemi-Replacement' Mitral Valve to the Clinic

June 14, 2018
Mindstrong Health Announces $15M Series B Round Financing and Business Update

May 10, 2018
Lilly Announces Agreement To Acquire ARMO BioSciences

January 25, 2018
ARMO BioSciences Announces Pricing of Initial Public Offering

December 14, 2017
GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer

December 8, 2017
EpiMab Biotherapeutics Wins Fortune China Innovation of the Year

November 13, 2017
Arcus Biosciences Announces $107 Million Series C Financing and Initiation of Two Clinical Trials

August 29, 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing

May 31, 2017
GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer

May 8, 2017
Aadi Bioscience Closes $23 Million in Series A Funding

May 3, 2017
Hummingbird Bioscience Closes a Venture Funding Round of an Undisclosed Amount from Decheng Capital

April 25, 2017
EpimAb Biotherapeutics Raises $25M in Series A Financing From International Consortium to Advance Pipeline of Novel Bispecific Antibodies

April 11, 2017
Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout

April 11, 2017
Bristol-Myers Squibb and Apexigen, Inc. Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with APX005M in Advanced Solid Tumors

December 14, 2016
ReadCoor Receives $2.5M Grant For Novel Pathogen Detection

October 25, 2016
First Scientist to Discover Fetal DNA in Plasma Co-Founds Cirina for Early Detection of Deadly Diseases

September 28, 2016
ReadCoor Announces Launch from Wyss Institute Following Completion of Series A Financing Round

September 27, 2016
SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

June 1, 2016
AccuraGen Raises $40M in Series B Financing

May 29, 2016
Dennis Lo, Co-founder of Cirina, featured on CNN

August 25, 2015
Becton Dickinson Acquires Single-Cell Genomics Startup Cellular Research

August 13, 2015
Roche Acquires GeneWEAVE for up to $425 Million to Strengthen Offerings in Microbiology Diagnostics

May 26, 2015
3SBio Attracts GIC, BlackRock to $712 Million Hong Kong IPO

February 19, 2015
China's 3SBio Eyes HK Listing Two Years After Going Private

February 11, 2015
Invitae Prices Upsized IPO Above Range at $16

January 9, 2015
Invitae Corporation Files Registration Statement for Proposed Initial Public Offering

October, 13, 2014
Invitae Completes $120 Million Series F Financing

July 2, 2014
GeneWeave Attracts $12 Million to Provide Same-Shift Sample-In/Susceptibility-Out Diagnostic Solutions for Multi-Drug-Resistant Organisms

February 14, 2014
GenapSys Featured on Forbes

November 14, 2013
GenapSys Raises $37M to Commercialize Next Generation Sequencing Platform

February 28, 2012
GeneWeave Biosciences Inks $12M

Decheng Capital News

March 19, 2017
Professor Dennis Lo, Decheng’s Advisor, Received the 2016 Future Science Prize Award

November 14, 2016
Dan Zabrowski Joins Decheng Capital as Venture Partner

September 20, 2016
Hong Kong Professor Dennis Lo Yuk-ming Bags First-ever Chinese Version of Nobel Prize

March 6, 2014
Mr. Robert King, Decheng’s Co-Anchor LP, Received the 2014 Arbuckle Award

June 6, 2013
Decheng Capital celebrates the final closing of USD Fund I

Copyright © 2011 Decheng Capital LLC. All Rights Reserved.